Equity Details
Price & Market Data
Price: $13.09
Daily Change: +$0.466 / 3.56%
Daily Range: $12.93 - $13.13
Market Cap: $924,484,288
Daily Volume: 8,035
Performance Metrics
1 Week: -19.05%
1 Month: -22.82%
3 Months: -19.15%
6 Months: -15.17%
1 Year: 34.84%
YTD: -25.92%
About Pharming Group N.V. (PHAR)
Discover the investment profile of Pharming Group N.V. (PHAR). With a price of 13.09, and a daily change of +$0.466 / 3.56%. Market cap: 924,484,288. Performance figures include YTD and 52-week returns.
Details
Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company's lead product is RUCONEST, a recombinant C1 esterase inhibitor for the treatment of acute attacks in adult and adolescent patients with acute hereditary angioedema (HAE); and Joenja (leniolisib), an oral small molecule PI3K? inhibitor for the treatment of activated phosphoinositide 3-kinase delta syndrome. It also develops Joenja, an oral small molecule PI3K? inhibitor. It has a development collaboration and license agreement with Novartis. Pharming Group N.V. was incorporated in 1988 and is headquartered in Leiden, the Netherlands.